Cupertino S, Goncalves A, Gusmao Lopes C, Gradia D, Beltrame M
Genes (Basel). 2025; 16(2).
PMID: 40004528
PMC: 11855290.
DOI: 10.3390/genes16020199.
Reid S, Fan R, Venton L, Weidner A, Tezak A, Roberson M
JAMA Netw Open. 2024; 7(12):e2449798.
PMID: 39652347
PMC: 11629124.
DOI: 10.1001/jamanetworkopen.2024.49798.
Zhao Y, Bai Y, Li M, Nie X, Meng H, Shosei S
J Nanobiotechnology. 2024; 22(1):420.
PMID: 39014462
PMC: 11253471.
DOI: 10.1186/s12951-024-02677-0.
Martini R, Davis M
Am J Hum Genet. 2024; 111(7):1261-1264.
PMID: 38996469
PMC: 11383922.
DOI: 10.1016/j.ajhg.2024.05.011.
Adam N, Wieder R
Biomedicines. 2024; 12(6).
PMID: 38927419
PMC: 11200891.
DOI: 10.3390/biomedicines12061213.
Investigating phenotypic plasticity due to toxicants with exposure disparities in primary human breast cells .
Schroeder J, Polemi K, Tapaswi A, Svoboda L, Sexton J, Colacino J
Front Oncol. 2024; 14:1411295.
PMID: 38915368
PMC: 11194339.
DOI: 10.3389/fonc.2024.1411295.
Immunohistochemistry-derived subtypes of breast cancer distribution in four regions of Ethiopia.
Belachew E, Desta A, Gebremariam T, Deneke D, Ashenafi S, Yeshi M
Front Endocrinol (Lausanne). 2023; 14:1250189.
PMID: 38027092
PMC: 10666628.
DOI: 10.3389/fendo.2023.1250189.
Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer.
Hossain F, Ucar D, Monticone G, Ran Y, Majumder S, Larter K
Front Immunol. 2023; 14:1244159.
PMID: 37901240
PMC: 10612326.
DOI: 10.3389/fimmu.2023.1244159.
Racial Disparities in Breast Cancer Treatments and Adverse Events in the SEER-Medicare Data.
Wieder R, Adam N
Cancers (Basel). 2023; 15(17).
PMID: 37686609
PMC: 10486612.
DOI: 10.3390/cancers15174333.
2-Hydroxypropyl-β-cyclodextrin (HPβCD) as a Potential Therapeutic Agent for Breast Cancer.
Saha S, Abdulla N, Zininga T, Shonhai A, Wadee R, Kaur M
Cancers (Basel). 2023; 15(10).
PMID: 37345165
PMC: 10216648.
DOI: 10.3390/cancers15102828.
Haplotypes of single cancer driver genes and their local ancestry in a highly admixed long-lived population of Northeast Brazil.
Galisa S, Jacob P, Farias A, Lemes R, Alves L, Nobrega J
Genet Mol Biol. 2022; 45(1):e20210172.
PMID: 35112701
PMC: 8811751.
DOI: 10.1590/1678-4685-GMB-2021-0172.
Comprehensive Analysis of the Effects of Genetic Ancestry and Genetic Characteristics on the Clinical Evolution of Oral Squamous Cell Carcinoma.
Liu X, Zeng Y, Liang T, Tang K, Guo J, Zheng W
Front Cell Dev Biol. 2021; 9:678464.
PMID: 34950653
PMC: 8689072.
DOI: 10.3389/fcell.2021.678464.
Identifying the link between chemical exposures and breast cancer in African American women via integrated in vitro and exposure biomarker data.
Polemi K, Nguyen V, Heidt J, Kahana A, Jolliet O, Colacino J
Toxicology. 2021; 463:152964.
PMID: 34600088
PMC: 8593892.
DOI: 10.1016/j.tox.2021.152964.
Building Capacity for Global Cancer Research: Existing Opportunities and Future Directions.
Sivaram S, Perkins S, He M, Ginsburg E, Dominguez G, Vedham V
J Cancer Educ. 2021; 36(Suppl 1):5-24.
PMID: 34273100
PMC: 8285681.
DOI: 10.1007/s13187-021-02043-w.
HSD17B7 gene in self-renewal and oncogenicity of keratinocytes from Black versus White populations.
Xu X, Tassone B, Ostano P, Katarkar A, Proust T, Joseph J
EMBO Mol Med. 2021; 13(7):e14133.
PMID: 34185380
PMC: 8261506.
DOI: 10.15252/emmm.202114133.
A network approach reveals driver genes associated with survival of patients with triple-negative breast cancer.
Dill C, Dammer E, Griffen T, Seyfried N, Lillard Jr J
iScience. 2021; 24(5):102451.
PMID: 34007962
PMC: 8111681.
DOI: 10.1016/j.isci.2021.102451.
Breast cancer in Zimbabwe: patterns of care and correlates of adherence in a national referral hospital radiotherapy center cohort from 2014 to 2018.
Cluff Elmore S, Mushonga M, Iyer H, Kanda C, Chibonda S, Chipidza F
Cancer Med. 2021; 10(11):3489-3498.
PMID: 33973399
PMC: 8178482.
DOI: 10.1002/cam4.3764.
Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort.
Martini R, Chen Y, Jenkins B, Elhussin I, Cheng E, Hoda S
Sci Rep. 2021; 11(1):9247.
PMID: 33927264
PMC: 8085076.
DOI: 10.1038/s41598-021-88613-w.
Disparities in Genetic Testing and Care among Black women with Hereditary Breast Cancer.
Reid S, Cadiz S, Pal T
Curr Breast Cancer Rep. 2021; 12(3):125-131.
PMID: 33603954
PMC: 7885902.
DOI: 10.1007/s12609-020-00364-1.
The Peony trial: adding evidence to pertuzumab use in non-metastatic breast cancer.
Cortadellas T, Gonzalez-Farre X
Gland Surg. 2020; 9(4):1086-1089.
PMID: 32953622
PMC: 7475362.
DOI: 10.21037/gs.2020.03.11.